CARDIOMETABOLIC RISK PREDICTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE COMBINED WITH SUBCLINICAL HYPOTHYROIDISM

One of the most common diseases of our time is non-alcoholic fatty liver disease (NAFLD). Recently published research results indicate that patients with NAFLD along with traditional risk factors for cardiovascular diseases (CVD) have "new" risk factors such as endothelial dysfunction (ED), carotid intima-media thickness (CIMT), an increase in the CRP level, as well as risk factors combined into the Framingham scale. It is also known that combination of NAFLD with subclinical hypothyroidism (SH) forms an abnormal metabolic phenotype, which is associated with cardiometabolic risk factors. The study of cardiometabolic predictors and vascular markers in patients with NAFLD in combination with SH will provide an opportunity to improve the strategy of cardiovascular events prevention in such comorbid patients.

Keywords:

cardiometabolic risk, non-alcoholic fatty liver disease, subclinical hypothyroidism, prediction, binary regression logistic analysis, validation of prognostic models

References

Bano A., Chaker L., Plompen E. P. C., et al.: Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study. J Clin Endocrinol Metab. 101(8), 2016, 3204–3211. DOI: https://doi.org/10.1210/jc.2016-1300

Belyalov F. I.: Prognozirovaniye i shkaly v kardiologii 2ye-izd. MEDPRESS-inform, Moscow 2018.

Belialov F. I.: Risk prediction scores of diseases. Complex Issues of Cardiovascular Diseases 7(1), 2018, 84–93 [http://doi.org/10.17802/2306-1278-2018-7-1-84-93]. DOI: https://doi.org/10.17802/2306-1278-2018-7-1-84-93

Georgiyants M., Khvysyuk O., Boguslavskaуa N. et al.: Development of a mathematical model for predicting postoperative pain among patients with limb injuries. Eastern-European Journal of Enterprise Technologies 2, N4(86), 2017, 4–9 [http://doi.org/10.15587/1729-4061.2017.95157]. DOI: https://doi.org/10.15587/1729-4061.2017.95157

Graham I., Atar D., Borch-Johnsen K. et al.: European guidelines on cardiovascular disease prevention in clinical practice: full text. Eur. J. Cardiovasc. Prev. Rehabil. 14, 2007, S1–S113.

Kojuri J., Boostani R., Dehghani P., Nowroozipour F., Saki N.: Prediction of acute myocardial infarction with artificial neural networks in patients with nondiagnostic electrocardiogram. Journal of Cardiovascular Disease Research. 6(2), 2015, 51–60. DOI: https://doi.org/10.5530/jcdr.2015.2.2

Kolesnikova E. V.: Sovremennyy patsiyent s zabolevaniyem pechenii patologiyey serdechno-sosudistoy sistemy: kakoy vybor sdelat? Contemporary gastroenterology 2(76), 2014, 85–94.

Kolesnikova O. V., Nemtsova V. D.: Effect of preventive measures for major metabolic parameters in patients with non-alcoholic fatty liver disease and cardiovascular risk. The ESC Textbook of Preventive Cardiology. Comprehensive, practical, and the official textbook of the European Association for Cardiovascular Prevention and Rehabilitation. Oxford University press, 2015.

Koval S. M., Snihurska I. O., Vysotska O. et al.: Prognosis of essential hypertension progression in patients with abdominal obesity. Wójcik W., Pavlov S., Kalimoldayev, M. (Eds.): Information Technology in Medical Diagnostics II. Taylor & Francis Group, CRC Press, Balkema book, London 2019. DOI: https://doi.org/10.1201/9780429057618-32

Krak I. V., Kryvonos I. G., Kulias A. I.: Applied aspects of the synthesis and analysis of voice information. Cybernetics and Systems Analysis 49(4), 2013, 589–596. DOI: https://doi.org/10.1007/s10559-013-9545-9

Krak I., Kondratiuk S.: Cross-platform software for the development of sign communication system: Dactyl language modelling. 12th International Scientific and Technical Conference on Computer Sciences and Information Technologies – CSIT, 2017, 1,8098760, 167–170 DOI: https://doi.org/10.1109/STC-CSIT.2017.8098760

Ludwig U., Holzner D., Denzer C. et al.: Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years. BMC Endocr Disord. 15. 2015, 41. DOI: https://doi.org/10.1186/s12902-015-0030-5

Ross D. S., Burch G. B, Cooper D. S. et al.: American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis. Thyroid 26(10), 2016, 1343–1421. DOI: https://doi.org/10.1089/thy.2016.0229

Sinn D. H., Cho S. J., Gu S. et al.: Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis. Gastroenterology 151(3), 2016, 481–488. DOI: https://doi.org/10.1053/j.gastro.2016.06.001

Strashnenko A. N., Vysotskaya E. V., Demin Y. A. et al.: A method for prognosis of primary open-angle glaucoma. International Review on Computers and Software 8, 2013, 1943–1949.

Weiwei He, Xiaofei An, Ling Li et al.: Relationship between Hypothyroidism and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Front Endocrinol (Lausanne) 8, 2017, 335. DOI: https://doi.org/10.3389/fendo.2017.00335

Weng S. F., Reps J., Kai J., Garibaldi J. M., Qureshi N.: Can machinelearning improve cardiovascular risk prediction using routine clinical data? PLOS ONE 12(4), 2017, e0174944 [http://doi.org/10.1371/journal.pone.0174944]. DOI: https://doi.org/10.1371/journal.pone.0174944

Kolesnikova, O., Vysotska, O., Potapenko, A., Radchenko, A., Trunova, A., Virstyuk, N., … Mukanova, N. (2023). CARDIOMETABOLIC RISK PREDICTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE COMBINED WITH SUBCLINICAL HYPOTHYROIDISM. Informatyka, Automatyka, Pomiary W Gospodarce I Ochronie Środowiska, 13(2), 64–68. https://doi.org/10.35784/iapgos.3654

CARDIOMETABOLIC RISK PREDICTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE COMBINED WITH SUBCLINICAL HYPOTHYROIDISM

Issue Vol. 13 No. 2 (2023)

Archives

DOI

Authors

Abstract

Keywords:

References

License

Article Sidebar

Issue Vol. 13 No. 2 (2023)

Archives

Main Article Content

DOI

Authors

Abstract

Keywords:

References

Article Details

License